Back
Doximity Vs. National Research Industry Stock Comparison
Buy
80
DOCS
Doximity
Last Price:
$57.92
Seasonality Move:
-0.88%
Sell
14
NRC
National Research
Last Price:
$17.16
Seasonality Move:
-3.7%
Sell
14
National Research (NRC)
is a Sell
Is National Research a Buy, Sell or Hold?
-
The current National Research [NRC] share price is $17.17. The Score for NRC is 14, which is 72% below its historic median score of 50, and infers higher risk than normal.
-
NRC is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing an extreme reading that indicates risk could be especially high.
NRC Stock Price Chart
What is National Research's stock price today?
-
The National Research share price today is $17.17Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NRC is experiencing slight selling pressure.
DOCS Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 1.52 | Buy |
Relative Strength Index (14 RSI): | 66.58 | Buy |
Chaikin Money Flow: | 6612860 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (50.31 - 54.95) | Buy |
Bollinger Bands (100): | (35.23 - 51.09) | Buy |
NRC Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.59 | Sell |
Relative Strength Index (14 RSI): | 35.82 | Sell |
Chaikin Money Flow: | -113210 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (17.89 - 19.67) | Sell |
Bollinger Bands (100): | (18.56 - 22.16) | Sell |
DOCS Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 53.57 | Buy |
20-day SMA: | 53.24 | Buy |
50-day SMA: | 48.91 | Buy |
200-day SMA: | 35.03 | Buy |
8-day EMA: | 54.33 | Buy |
20-day EMA: | 53.05 | Buy |
50-day EMA: | 49.46 | Buy |
200-day EMA: | 38.67 | Buy |
NRC Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 17.7 | Sell |
20-day SMA: | 18.74 | Sell |
50-day SMA: | 18.94 | Sell |
200-day SMA: | 25.58 | Sell |
8-day EMA: | 17.68 | Sell |
20-day EMA: | 18.39 | Sell |
50-day EMA: | 19.21 | Sell |
200-day EMA: | 25 | Sell |
Doximity Earnings Growth & DOCS Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.02 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.20 per share, and an increase next year of $0.25 per share.
National Research Earnings Growth & NRC Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Doximity Technical Analysis
Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
National Research Technical Analysis
Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |